People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Other, Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Skyword Inc. | — | Other | Series B | $58.8M | $89.9M | 2020 |
| newBrandAnalytics, Inc. | — | Other Technology | Series B | $32.2M | $153.3M | 2013 |
| Affect Therapeutics, Inc. | — | Pharma | Series B | $24.6M | $232.7M | 2021 |
| pgEdge, Inc. | — | Other Technology | Series B | $22.7M | $25.5M | 2025 |
Kristin Muhlner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kristin Muhlner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Harry Weller | 1 | 21 |
| Kevin Ryan | 1 | 20 |
| Dayna Grayson | 1 | 13 |
| Stuart Peterson | 1 | 7 |
| Jim Manzi | 1 | 6 |
| Tige Savage | 1 | 6 |
| Gene Riechers | 1 | 5 |
| Jeff DeFlavio | 1 | 5 |
| Andrew Wheeler | 1 | 5 |
| Sean O'Leary | 1 | 5 |
| Jeff Rinehart | 1 | 4 |
| Jeff Webber | 1 | 4 |
| Neil Kataria | 1 | 3 |
| Gar Richlin | 1 | 3 |
| Jim P. Manzi | 1 | 3 |
| Roger Blanchette | 1 | 3 |
| Leonard Kurtzman | 1 | 3 |
| William Savage | 1 | 2 |
| William W. Bradley | 1 | 2 |
| Kam Desai | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.